Reaction
Pseudoendophthalmitis reporting signals
As of the last recalculation, Pseudoendophthalmitis appears in 99 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is TRIAMCINOLONE ACETONIDE (PRR 252.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Triamcinolone Acetonide | 27 | 252.3 | 252.5 |
| Ranibizumab | 19 | 186.0 | 186.1 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 17 | 184.1 | 184.2 |
| Faricimab | 6 | 165.6 | 165.8 |
| Aflibercept | 19 | 158.2 | 158.3 |